Literature DB >> 21077960

Prognostic variables and nomograms for renal cell carcinoma.

Robert C Flanigan1, Anthony J Polcari, Cory M Hugen.   

Abstract

The term renal cell carcinoma (RCC) is used to describe a heterogeneous group of tumors that vary histologically, genetically and molecularly. Extensive research has been conducted to identify characteristics that predict outcomes among patients with RCC. In addition to histological subtype these include tumor size, patient age, mode of presentation and various hematological indices, among others. Several groups have incorporated these clinical and pathological features into nomograms which help the clinician better define individual patient prognosis and direct the optimum therapeutic approach. In the present article we review these prognostic variables and nomograms for RCC.
© 2010 The Japanese Urological Association.

Entities:  

Mesh：

Year:  2010        PMID： 21077960     DOI： 10.1111/j.1442-2042.2010.02642.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


  7 in total

1.  [Renal cell carcinoma: Drug therapy and prognostic models].

Authors:  M A Reiter; M Kurosch; A Haferkamp
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

2.  Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.

Authors:  Hebert Alberto Vargas; Holly G Delaney; Eithne M Delappe; Ya Wang; Junting Zheng; Chaya S Moskowitz; Yongqiang Tan; Binsheng Zhao; Lawrence H Schwartz; Hedvig Hricak; Paul Russo; Oguz Akin
Journal:  J Magn Reson Imaging       Date:  2012-11-13       Impact factor: 4.813

3.  Novel cut-off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long-term, follow-up, retrospective study.

Authors:  Chuanzhen Cao; Jianzhong Shou; Hongzhe Shi; Weixing Jiang; Xiangpeng Kang; Ruiyang Xie; Bingqing Shang; Xingang Bi; Jin Zhang; Shan Zheng; Aiping Zhou; Changling Li; Jianhui Ma
Journal:  Int J Urol       Date:  2021-11-30       Impact factor: 2.896

4.  Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma.

Authors:  Sebastian L Hofbauer; Michela de Martino; Christoph Seemann; Nura Zamani; Ilaria Lucca; Andrea Haitel; Shahrokh F Shariat; Tobias Klatte
Journal:  Korean J Urol       Date:  2014-08-08

5.  Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.

Authors:  Guanghao Zhang; Yun Wu; Jiashu Zhang; Zhiqing Fang; Zhaoxu Liu; Zhonghua Xu; Yidong Fan
Journal:  Onco Targets Ther       Date:  2018-09-06       Impact factor: 4.147

6.  The effect of antioxidant status on overall survival in renal cell carcinoma.

Authors:  Ivan Pavlović; Snežana Pejić; Sanja Radojević-Škodrić; Ana Todorović; Vesna Stojiljković; Ljubica Gavrilović; Nataša Popović; Gordana Basta-Jovanović; Zoran Džamić; Snežana B Pajović
Journal:  Arch Med Sci       Date:  2019-07-22       Impact factor: 3.318

7.  Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece.

Authors:  Nikolaos Grivas; Vasilios Kafarakis; Ioannis Tsimaris; Pavlos Raptis; Konstantinos Hastazeris; Nikolaos E Stavropoulos
Journal:  Urol Ann       Date:  2014-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.